Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 49: 1873-1880, 2003; 10.1373/clinchem.2003.022558
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow View responses
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (20)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Frohlich, J.
Right arrow Articles by Dobiásová, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Frohlich, J.
Right arrow Articles by Dobiásová, M.
Related Collections
Right arrow Lipids, Lipoproteins, and Cardiovascular Risk Factors
(Clinical Chemistry. 2003;49:1873-1880.)
© 2003 American Association for Clinical Chemistry, Inc.


Lipids, Lipoproteins, and Cardiovascular Risk Factors

Fractional Esterification Rate of Cholesterol and Ratio of Triglycerides to HDL-Cholesterol Are Powerful Predictors of Positive Findings on Coronary Angiography

Jiri Frohlich1,a and Milada Dobiásová2

1 Department of Pathology and Laboratory Medicine, University of British Columbia, Healthy Heart Program/Lipid Clinic, St. Paul’s Hospital, Vancouver, BC V6Z 1Y6, Canada.

2 Institute of Physiology, Academy of Sciences of the Czech Republic, Prague, Czech Republic 14220.

aAddress correspondence to this author at: Healthy Heart Program, St. Paul’s Hospital, B180-1081 Burrard St., Vancouver, BC V6Z 1Y6, Canada. Fax 604-806-8590/3; e-mail jifr{at}interchange.ubc.ca.

Background: We examined the predictive value of various clinical and biochemical markers for angiographically defined coronary artery disease (aCAD). Specifically, we assessed the value of the ratio of plasma triglyceride (TGs) to HDL-cholesterol (HDL-C) and the fractional esterification rate of cholesterol in plasma depleted of apolipoprotein B (apoB)-containing lipoproteins (FERHDL), a functional marker of HDL and LDL particle size.

Methods: Patients (788 men and 320 women) undergoing coronary angiography were classified into groups with positive [aCAD(+)] and negative [aCAD(-)] findings. Patient age, body mass index, waist circumference, blood pressure (BP), medications, drinking, smoking, exercise habits, and plasma total cholesterol (TC), LDL-cholesterol (LDL-C), HDL-unesterified cholesterol, HDL-C, TGs, FERHDL, apoB, log(TG/HDL-C), and TC/HDL-C were assessed. Lipids and apoproteins were measured by standard laboratory procedures; FERHDL was determined by a radioassay.

Results: Members of the aCAD(+) group were older and had a higher incidence of smoking and diabetes than those in the aCAD(-) group. The aCAD(+) group also had higher TG, apoB, FERHDL, and log(TG/HDL-C) and lower HDL-C values. aCAD(+) women had greater waist circumference and higher plasma TC and TC/HDL-C. aCAD(+) men, but not women, had higher plasma LDL-C. In the multivariate logistic model, the significant predictors of the presence of aCAD(+) were FERHDL, age, smoking, and diabetes. If only laboratory tests were included in the multivariate logistic model, FERHDL appeared as the sole predictor of aCAD(+). Log(TG/HDL-C) was an independent predictor when FERHDL was omitted from multivariate analysis.

Conclusions: FERHDL was the best laboratory predictor of the presence of coronary atherosclerotic lesions.




The following articles in journals at HighWire Press have cited this article:


Home page
Clin. Chem.Home page
R. Movva and D. J. Rader
Laboratory Assessment of HDL Heterogeneity and Function
Clin. Chem., May 1, 2008; 54(5): 788 - 800.
[Abstract] [Full Text] [PDF]


Home page
CMAJHome page
K. W.J. Lee, J. S. Hill, K. R. Walley, and J. J. Frohlich
Relative value of multiple plasma biomarkers as risk factors for coronary artery disease and death in an angiography cohort.
Can. Med. Assoc. J., February 14, 2006; 174(4): 461 - 466.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
M. Suzuki, H. Wada, S. Maeda, K. Saito, S. Minatoguchi, K. Saito, and M. Seishima
Increased Plasma Lipid-Poor Apolipoprotein A-I in Patients with Coronary Artery Disease
Clin. Chem., January 1, 2005; 51(1): 132 - 137.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
A. Brehm, G. Pfeiler, G. Pacini, H. Vierhapper, and M. Roden
Relationship between Serum Lipoprotein Ratios and Insulin Resistance in Obesity
Clin. Chem., December 1, 2004; 50(12): 2316 - 2322.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
B. Zhang, P. Fan, E. Shimoji, H. Xu, K. Takeuchi, C. Bian, and K. Saku
Inhibition of Cholesteryl Ester Transfer Protein Activity by JTT-705 Increases Apolipoprotein E-Containing High-Density Lipoprotein and Favorably Affects the Function and Enzyme Composition of High-Density Lipoprotein in Rabbits
Arterioscler. Thromb. Vasc. Biol., October 1, 2004; 24(10): 1910 - 1915.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
M. Dobiasova
Atherogenic Index of Plasma [Log(Triglycerides/HDL-Cholesterol)]: Theoretical and Practical Implications
Clin. Chem., July 1, 2004; 50(7): 1113 - 1115.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
M. H. Tan, D. Johns, and N. B. Glazer
Pioglitazone Reduces Atherogenic Index of Plasma in Patients with Type 2 Diabetes
Clin. Chem., July 1, 2004; 50(7): 1184 - 1188.
[Abstract] [Full Text] [PDF]

eLetters:

Read all eLetters

Direct Staining of Triglyceride and Cholesterol in LDL
Toshio Okazaki, et al.
Clinical Chemistry Online, 17 Apr 2004 [Full text]



HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the American Association for Clinical Chemistry.